BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, December 15, 2025
See today's BioWorld
Home
» Other news to note for March 9, 2021
To read the full article
sign up for free
or
sign in
.
Other news to note for March 9, 2021
March 9, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: AC Immune, Affinivax, Allarity, Arkuda, Asceneuron, Biodextris, Biolojic, Boston Immune, Cambridge Allergy, Capricor, Centogene, Compugen, Dewpoint, Durect, Eli Lilly, Exevir, Genome and Co., Greenlight, Immunitybio, Immunoscape, Insilico, Medolife, Merck & Co., Merck KGaA, Nantkwest, Neurorx, Oragenics, Orionis, Pfizer, Promatix, PTC, Scisparc, Selexis, Soligenix, Sorrento, Surface Oncology, Taysha, TFF, Twelve Bio, UCB, Valo, Volastra, Yumanity.
BioWorld
Briefs
Other news to note
Coronavirus